Excellent long term survival of front-line high-dose chemotherapy with rituximab (HDT) in

被引：0
|
作者：
Dilhuydy, M. [1 ]
Lamy, T. [2 ]
Casassus, P. [3 ]
Deconninck, E. [4 ]
Gressin, R. [5 ]
Le Maignan, C. [6 ]
Milpied, N. [1 ]
机构：
[1] CHU Bordeaux, F-93009 Pessac, France
[2] CHU Rennes, F-25030 Rennes, France
[3] Hop Avicenne, Bobigny, France
[4] CHU Besancon, Hematol & BMT Unit, Besancon, France
[5] Hop Michallon, Grenoble, France
[6] Hop Europeen Georges Pompidou, Paris, France
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [41] HIGH-DOSE CEF (CYCLOPHOSPHAMIDE, EPIRUBICIN, FLUOROURACIL) AS PRIMARY CHEMOTHERAPY IN LOCALLY ADVANCED BREAST CANCER: LONG TERM SURVIVAL DATA
    Conti, F.
    Perri, P.
    Sperduti, I.
    Amodio, A.
    Carpano, S.
    Foggi, P.
    Anza, M.
    Della Giulia, M.
    Lopez, M.
    EJC SUPPLEMENTS, 2008, 6 (14): : 115 - 115
  • [42] Improvement of Long-Term Survival after High-Dose Melphalan in Patients with Light Chain Amyloidosis Responding to Induction Chemotherapy
    Mangatter, Anja
    Schoenland, Stefan
    Hansberg, Marion
    Bochtler, Tilmann
    Dietrich, Sascha
    Dreger, Peter
    Neben, Kai
    Ho, Anthony
    Goldschmidt, Hartimut
    Hegenbart, Ute
    BLOOD, 2008, 112 (11) : 1145 - 1146
  • [43] Long-term survival and late toxicities after high-dose chemotherapy in patients suffering from germ cell cancer
    Rick, O
    Beyer, J
    Schwella, N
    Kingreen, D
    Krusch, A
    Huhn, D
    Siegert, W
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 156 - 156
  • [44] LONG-TERM SURVIVAL IN A PATIENT WITH MALIGNANT CARCINOID TREATED WITH HIGH-DOSE OCTREOTIDE
    DEGUCHI, H
    DEGUCHI, K
    TSUKADA, T
    MURASHIMA, S
    IWASAKI, E
    TSUDA, M
    KOBAYASHI, T
    SHIRAKAWA, S
    INTERNAL MEDICINE, 1994, 33 (02) : 100 - 102
  • [45] RITUXIMAB AND CHLORAMBUCIL AS FRONT-LINE TREATMENT FOR FOLLICULAR LYMPHOMA: EXTENDED DISEASE FREE SURVIVAL WITHOUT INCREASED TOXICITY
    Bassi, S.
    Sammassimo, S.
    Gigli, F.
    Negri, M.
    Cocorocchio, E.
    Gardellini, A.
    Rabascio, C.
    Calleri, A.
    Pruneri, G.
    Peccatori, F.
    Laszlo, D.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 109 - 109
  • [46] Long Term Outcomes of Rituximab, Temozolamide, and High-Dose Methotrexate for Lymphoma Involving the Central Nervous System
    Nagle, Sarah Jordan
    Shah, Nirav N.
    Ganetsky, Alex
    Landsburg, Daniel J.
    Nasta, Sunita Dwivedy
    Mato, Anthony
    Schuster, Stephen J.
    Tsai, Donald Edward
    Svoboda, Jakub
    BLOOD, 2015, 126 (23)
  • [47] Preparedness for Resident Death in Long-Term Care: The Experience of Front-Line Staff
    van Riesenbeck, Isabelle
    Boerner, Kathrin
    Barooah, Adrita
    Burack, Orah R.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 50 (01) : 9 - 16
  • [48] High-dose therapy and autologous stem cell transplantation following platinum-free high-dose cytarabine induction results in excellent long term survival in younger patients with mantle cell lymphoma
    Baermann, B. -N.
    Jaeger, P.
    Chae, J. H.
    Ulrych, T.
    Nachtkamp, K.
    Fenk, R.
    Germing, U.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 300 - 301
  • [49] Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study
    Shi, Tingyan
    Jiang, Rong
    Pu, Hong
    Yang, Huijuan
    Tu, Dongsheng
    Dai, Zhiyuan
    Cai, Yunlang
    Zhang, Yuqin
    Cheng, Xi
    Jia, Huixun
    Tu, Ruiqin
    Wang, Huaying
    Tang, Jie
    Luan, Yuting
    Cai, Shumo
    Zang, Rongyu
    BRITISH JOURNAL OF CANCER, 2019, 121 (05) : 425 - 428
  • [50] Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study
    Tingyan Shi
    Rong Jiang
    Hong Pu
    Huijuan Yang
    Dongsheng Tu
    Zhiyuan Dai
    Yunlang Cai
    Yuqin Zhang
    Xi Cheng
    Huixun Jia
    Ruiqin Tu
    Huaying Wang
    Jie Tang
    Yuting Luan
    Shumo Cai
    Rongyu Zang
    British Journal of Cancer, 2019, 121 : 425 - 428
12345